The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Open accessAbstract
Multiple sclerosis is a common disease of the central nervous system in which the interplay between inflammatory and neurodegenerative processes typically results in intermittent neurological disturbance followed by progressive accumulation of disability. Epidemiological studies have shown that genetic factors are primarily responsible for the substantially increased frequency of the disease seen in the relatives of affected individuals, and systematic attempts to identify linkage in multiplex families have confirmed that variation within the major histocompatibility complex (MHC) exerts the greatest individual effect on risk. Modestly powered genome-wide association studies (GWAS) have enabled more than 20 additional risk loci to be identified and have shown that multiple variants exerting modest individual effects have a key role in disease susceptibility. Most of the genetic architecture underlying susceptibility to the disease remains to be defined and is anticipated to require the analysis of sample sizes that are beyond the numbers currently available to individual research groups. In a collaborative GWAS involving 9,772 cases of European descent collected by 23 research groups working in 15 different countries, we have replicated almost all of the previously suggested associations and identified at least a further 29 novel susceptibility loci. Within the MHC we have refined the identity of the HLA-DRB1 risk alleles and confirmed that variation in the HLA-A gene underlies the independent protective effect attributable to the class I region. Immunologically relevant genes are significantly overrepresented among those mapping close to the identified loci and particularly implicate T-helper-cell differentiation in the pathogenesis of multiple sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The role of the adaptive arm of the immune system, particularly its CD4+ T cell component has become clearer, with multiple different T cell subsets being implicated.(4)”
From Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility (2019) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the role of B cells, dendritic cells and natural killer cells has emerged more clearly, broadening the prior narrative of T cell dysregulation that emerged from earlier studies.(4)”
From Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility (2019) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“published efforts to systematically interrogate severity have, thus far, only involved modest numbers of cases, and unanimously fall short of identifying any convincingly associated genetic variants5,10,11.”
From Locus for severity implicates CNS resilience in progression of multiple sclerosis (2023) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“refinement of the associations in the HLA region showed that just four variants are sufficient to account for the risk previously attributed to extended haplotype alleles spanning hundreds of kilobases (kb) and many tens of genes.”
From Genome‐wide association studies of multiple sclerosis (2018) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the GWAS enrichment studies all point to risk being mediated by gene regulation in CD4+ T cells43”
From Genome‐wide association studies of multiple sclerosis (2018) · cites this paper as [43]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several studies have explored the genetic basis of clinical course, age of onset and severity, although no genome‐wide significant associations have been discovered.36, 37, 43, 74, 75, 76, 77”
From Genome‐wide association studies of multiple sclerosis (2018) · cites this paper as [43]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Although these risk variants have been found to reduce the age at onset5, it is notable that they do not appear to have any impact on disease severity6.”
From Locus for severity implicates CNS resilience in progression of multiple sclerosis (2023) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“A further expansion of the IMSGC resulted in a collaborative GWAS of 9772 cases and 17 376 controls, again of European descent, in 2011.43 This study replicated 23 of 26 previously identified associations and identified 29 novel risk loci.”
From Genome‐wide association studies of multiple sclerosis (2018) · cites this paper as [43]
The cited source says what the claim attributes to it.
In the citing paper
“it became evident that these loci are strongly enriched for genes acting in T‐cell activation and proliferation pathways.”
From Genome‐wide association studies of multiple sclerosis (2018) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Compston, A., & Coles, A. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,699
Genomic Control for Association Studies
Devlin, B., & Roeder, K. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00997.x · Cited by 3,162 · cited 1×
“However, even use of all seven top principal components that captured genome-wide effects in our data resulted in an unacceptably high genomic inflation: for example, the genomic control facto”
Variance component model to account for sample structure in genome-wide association studies
Kang, H. M., Sul, J. H., Service, S. K., Zaitlen, N. A., Kong, S.-Y., Freimer, N. B., Sabatti, C., & Eskin, E. (2010) · Nature Genetics · doi:10.1038/ng.548 · Cited by 2,817
Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa073493 · Cited by 1,746
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants
Wellcome Trust Case Control Consortium, & The Australo-Anglo-American Spondylitis Consortium (TASC) (2007) · Nature Genetics · doi:10.1038/ng.2007.17 · Cited by 1,374
Strange, A., Spencer, C. C. A., Band, G., Bellenguez, C., Freeman, C., Pirinen, M., Rautanen, A., Su, Z., Donnelly, P., Capon, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.694 · Cited by 1,056
International MS Genetics Consortium, De Jager, P. L., Jia, X., Wang, J., de Bakker, P. I. W., Ottoboni, L., Aggarwal, N. T., Piccio, L., Raychaudhuri, S., Tran, D., et al. (2009) · Nature Genetics · doi:10.1038/ng.401 · Cited by 800
The Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene) (2009) · Nature Genetics · doi:10.1038/ng.396 · Cited by 550
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
Baranzini, S. E., Wang, J., Gibson, R. A., Galwey, N., Naegelin, Y., Barkhof, F., Radue, E.-W., Lindberg, R. L. P., Uitdehaag, B. M. G., Johnson, M. R., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn388 · Cited by 476
Cited by
Sorted by citations
Items 901–1,000 of 1,003
Multiple sclerosis is prominent in the Gulf states: Review
Mohammed, E. M. A. (2016) · Pathogenesis · doi:10.1016/j.pathog.2016.04.001 · Cited by 38
Schwab, N., Schneider‐Hohendorf, T., Hoyt, T., Groß, C. C., Meuth, S. G., Klotz, L., Foley, J. F., & Wiendl, H. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517728814 · Cited by 37
Continental influx and pervasive matrilocality in Iron Age Britain
Cassidy, L. M., Russell, M., Smith, M. J., Delbarre, G., Cheetham, P., Manley, H., Mattiangeli, V., Breslin, E. M., Jackson, I., McCann, M., et al. (2025) · Nature · doi:10.1038/s41586-024-08409-6 · Cited by 42
Interferon-β Suppresses Murine Th1 Cell Function in the Absence of Antigen-Presenting Cells
Boivin, N., Baillargeon, J., Doss, P. M. I. A., Roy, A.-P., & Rangachari, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124802 · Cited by 39
Is the CCR5 Δ 32 Mutation Associated with Immune System-Related Diseases?
Ghorban, K., Dadmanesh, M., Hassanshahi, G., Momeni, M., Zare‐Bidaki, M., Arababadi, M. K., & Kennedy, D. D. (2012) · Inflammation · doi:10.1007/s10753-012-9585-8 · Cited by 36
The Evidence for Hypoperfusion as a Factor in Multiple Sclerosis Lesion Development
Juurlink, B. H. J. (2013) · Multiple Sclerosis International · doi:10.1155/2013/598093 · Cited by 36
Association of SNPs of CD40 Gene with Multiple Sclerosis in Russians
Sokolova, E. А., Malkova, N. A., Korobko, D. S., Rozhdestvenskiĭ, A. S., Kakulya, A. V., Ханох, Е. В., Ra, D., Платонов, Ф. А., Popova, T., Геннадьевна, А. Е., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061032 · Cited by 36
Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus
Ottoboni, L., Frohlich, I. Y., Lee, M. H., Healy, B. C., Keenan, B. T., Xia, Z., Chitnis, T., Guttmann, C. R. G., Khoury, S. J., Weiner, H. L., et al. (2013) · Neurology · doi:10.1212/01.wnl.0000436612.66328.8a · Cited by 37
Muris, A., Smolders, J., Rolf, L., Klinkenberg, L. J. J., van der Linden, N., Meex, S. J. R., Damoiseaux, J. G. M. C., & Hupperts, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156122 · Cited by 36
Cao, G., Wang, Q., Huang, W., Tong, J., Ye, D., He, Y., Liu, Z., Tang, X., Cheng, H., Wen, Q., et al. (2017) · Cell Discovery · doi:10.1038/celldisc.2017.20 · Cited by 37
Elevated EBNA-1 IgG in MS is associated with genetic MS risk variants
Kreft, K. L., van Nierop, G. P., Scherbeijn, S. M. J., Janssen, M., Verjans, G. M. G. M., & Hintzen, R. Q. (2017) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000406 · Cited by 36
Gut environmental factors and multiple sclerosis
Miyake, S., & Yamamura, T. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.07.015 · Cited by 36
Vitamin D Supplementation in Central Nervous System Demyelinating Disease—Enough Is Enough
Häusler, D., & Weber, M. S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010218 · Cited by 36
von Essen, M. R., Søndergaard, H. B., Petersen, E. R., & Sellebjerg, F. T. (2019) · Cells · doi:10.3390/cells8030285 · Cited by 36
Beecham, A. H., Amezcua, L., Chinea, A. R., Manrique, C., Rubí, C., Isobe, N., Lund, B., Santaniello, A., Beecham, G. W., Burchard, E. G., et al. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458519863764 · Cited by 37
Contributions of T cells in multiple sclerosis: what do we currently know?
Arneth, B. M. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10275-x · Cited by 36
de la Hera, B., Varadé, J., Montojo, M. G., Lamas, J. R., de la Encarnación, A., Arroyo, R., Fernández‐Gutiérrez, B., Álvarez‐Lafuente, R., & Urcelay, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062090 · Cited by 36
The essential role of t cells in multiple sclerosis: A reappraisal
Constantinescu, C. S., & Gran, B. (2014) · Biomedical Journal · doi:10.4103/2319-4170.128746 · Cited by 36
Song, L., Zhou, Q., Wang, H., Liao, F.-J., Hua, L., Zhang, H., Huang, L., Lin, Y., & Zheng, G. (2017) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2017.02.004 · Cited by 36
Dysregulation of MS risk genes and pathways at distinct stages of disease
Srinivasan, S., Dario, M. D., Russo, A., Menon, R., Brini, E., Romeo, M. A. L., Sangalli, F., Costa, G. D., Rodegher, M., Radaelli, M., et al. (2017) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000337 · Cited by 36
Weissert, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00336 · Cited by 37
Gil‐Varea, E., Urcelay, E., Vilariño‐Güell, C., Costa, C., Midaglia, L. S., Matesanz, F., Antigüedad, A. R., Oksenberg, J. R., Espino‐Paisán, L., Sadovnick, A. D., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1307-1 · Cited by 37
Genetics and familial distribution of multiple sclerosis: A review
Balcerac, A., & Louapre, C. (2022) · Revue Neurologique · doi:10.1016/j.neurol.2021.11.009 · Cited by 35
Akbari, P., Vuckovic, D., Stefanucci, L., Jiang, T., Kundu, K., Kreuzhuber, R., Bao, E. L., Collins, J., Downes, K., Grassi, L., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40679-y · Cited by 38
Ancient DNA reveals reproductive barrier despite shared Avar-period culture
Wang, K., Tóbiás, B., Pany‐Kucera, D., Berner, M. E., Eggers, S., Gnecchi‐Ruscone, G. A., Zlámalová, D., Gretzinger, J., Ingrová, P., Rohrlach, A. B., et al. (2025) · Nature · doi:10.1038/s41586-024-08418-5 · Cited by 37
NFAT1 deficit and NFAT2 deficit attenuate EAE via different mechanisms
Dietz, L., Frommer, F., Vogel, A., Vaeth, M., Serfling, E., Waisman, A., Buttmann, M., & Berberich‐Siebelt, F. (2015) · European Journal of Immunology · doi:10.1002/eji.201444638 · Cited by 35
Accurate liability estimation improves power in ascertained case-control studies
Weissbrod, O., Lippert, C., Geiger, D., & Heckerman, D. E. (2015) · Nature Methods · doi:10.1038/nmeth.3285 · Cited by 35
Vitamin D–gene interactions in multiple sclerosis
Berlanga‐Taylor, A. J., Disanto, G., Ebers, G. C., & Ramagopalan, S. V. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.08.041 · Cited by 35
Zhang, J., Zhang, Y., Yang, J., Zhang, L., Sun, L., Pan, H., Hirankarn, N., Ying, D., Zeng, S., Lee, T. L., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt424 · Cited by 35
Association of Genetic Markers with CSF Oligoclonal Bands in Multiple Sclerosis Patients
Leone, M. A., Barizzone, N., Esposito, F., Lucenti, A., Harbo, H. F., Goris, A., Kockum, I. S., Oturai, A. B., Celius, E. G., Mero, I., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064408 · Cited by 35
The gateway theory: bridging neural and immune interactions in the CNS
Kamimura, D., Yamada, M., Harada, M., Sabharwal, L., Meng, J., Bando, H., Ogura, H., Atsumi, T., Arima, Y., & Murakami, M. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00204 · Cited by 35
Li, M. J., Liu, Z., Liu, Z., Yan, B., Pan, Z., Huang, D., Liang, Q., Ying, D., Xu, F., Yao, H., et al. (2017) · Genome biology · doi:10.1186/s13059-017-1177-3 · Cited by 36
Detailed Characterization of T Cell Receptor Repertoires in Multiple Sclerosis Brain Lesions
Planas, R., Metz, I., Martinꝉ, R., & Sospedra, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00509 · Cited by 35
Dutch population structure across space, time and GWAS design
Byrne, R. P., van Rheenen, W., van den Berg, L. H., Veldink, J. H., & McLaughlin, R. L. (2020) · Nature Communications · doi:10.1038/s41467-020-18418-4 · Cited by 39
Genetic factors for susceptibility to and manifestations of neuromyelitis optica
Matsushita, T., Masaki, K., Isobe, N., Sato, S., Yamamoto, K., Nakamura, Y., Watanabe, M., Suenaga, T., & Kira, J. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51147 · Cited by 35
Aryl Hydrocarbon Receptor Plasma Agonist Activity Correlates With Disease Activity in Progressive MS
Tsaktanis, T., Beyer, T., Nirschl, L., Linnerbauer, M., Grummel, V., Bussas, M., Tjon, E. C., Mühlau, M., Korn, T., Hemmer, B., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000933 · Cited by 36
Natural Killer Cells in Multiple Sclerosis: Entering the Stage
Beliën, J., Goris, A., & Matthys, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.869447 · Cited by 35
Pallier, P. N., Ferrara, M., Romagnolo, F., Ferretti, M. T., Soreq, H., & Cerase, A. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102353 · Cited by 37
Rola ludzkich endogennych retrowirusów w patogenezie chorób autoimmunologicznych
Brodziak, A., Ziółko, E., Muc‐Wierzgoń, M., Nowakowska‐Zajdel, E., Kokot, T., & Klakla, K. (2012) · Medical Science Monitor · doi:10.12659/msm.882892 · Cited by 35
Ponsonby, A., Symeonides, C., Vuillermin, P., Mueller, J. F., Sly, P. D., & Saffery, R. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2016.05.011 · Cited by 35
TCR-stimulated changes in cell surface CD46 expression generate type 1 regulatory T cells
Choileáin, S. N., Hay, J., Thomas, J., Williams, A., Vermeren, M., Bénézech, C., Gomez-Salazar, M. A., Hugues, O. R., Vermeren, S., Howie, S., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aah6163 · Cited by 38
Sparks, A. M., Watt, K., Sinclair, R., Pilkington, J. G., Pemberton, J. M., McNeilly, T. N., Nussey, D. H., & Johnston, S. E. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008461 · Cited by 37
Multiple Sclerosis: An Overview of Epidemiology, Risk Factors, and Serological Biomarkers
Shi, M.-C., Liu, Y., Gong, Q., & Xu, X.-R. (2024) · Acta Neurologica Scandinavica · doi:10.1155/2024/7372789 · Cited by 36
A disease-specific convergence of host and Epstein–Barr virus genetics in multiple sclerosis
Mechelli, R., Umeton, R., Bellucci, G., Bigi, R., Rinaldi, V., Angelini, D. F., Guerrera, G., Pignalosa, F. C., Ilari, S., Patrone, M., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2418783122 · Cited by 36
The Fine Balance of Chemokines During Disease: Trafficking, Inflammation, and Homeostasis
Cardona, S. M., Garcia, J. A., & Cardona, A. E. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-426-5_1 · Cited by 34
Vitamin D and multiple sclerosis-from epidemiology to prevention
Sundström, P., & Salzer, J. (2015) · Acta Neurologica Scandinavica · doi:10.1111/ane.12432 · Cited by 34
The Retrovirus/Superantigen Hypothesis of Multiple Sclerosis
Emmer, A., Staege, M. S., & Kornhuber, M. E. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0100-7 · Cited by 34
de la Hera, B., Varadé, J., Montojo, M. G., Alcina, A., Fedetz, M., Alloza, I., Astobiza, I., Leyva, L., Fernández, Ó., Izquierdo, G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090182 · Cited by 34
Sabharwal, L., Kamimura, D., Meng, J., Bando, H., Ogura, H., Nakayama, C., Jiang, J., Kumai, N., Suzuki, H., Atsumi, T., et al. (2014) · The Journal of Biochemistry · doi:10.1093/jb/mvu057 · Cited by 34
Moen, S. M., Celius, E. G., Sandvik, L., Brustad, M., Nordsletten, L., Eriksen, E. F., & Holmøy, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045703 · Cited by 34
Leuenberger, T., Paterka, M., Reuter, E., Herz, J., Niesner, R. A., Radbruch, H., Bopp, T., Zipp, F., & Siffrin, V. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300822 · Cited by 34
Reduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis
Hares, K. M., Kemp, K. C., Rice, C. M., Gray, E., Scolding, N. J., & Wilkins, A. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513508836 · Cited by 34
Deciphering the role of DNA methylation in multiple sclerosis: emerging issues
Sokratous, M., Dardiotis, E., Tsouris, Z., Bellou, E., Michalopoulou, A., Siokas, V., Arseniou, S., Stamati, T., Tsivgoulis, G. K., Bogdanos, D. P., et al. (2016) · Autoimmunity Highlights · doi:10.1007/s13317-016-0084-z · Cited by 34
Variation within MBP gene predicts disease course in multiple sclerosis
Zhou, Y., Simpson, S., Charlesworth, J., van der Mei, I. A. F., Lucas, R. M., Ponsonby, A., AUSLONG Investigators Group, & Taylor, B. V. (2017) · Brain and Behavior · doi:10.1002/brb3.670 · Cited by 34
CpG Island Methylation Patterns in Relapsing-Remitting Multiple Sclerosis
Sokratous, M., Dardiotis, E., Bellou, E., Tsouris, Z., Michalopoulou, A., Dardioti, M., Siokas, V., Rikos, D., Tsatsakis, A. M., Kovatsi, L., et al. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1046-x · Cited by 34
Smoking and its interaction with genetics in MS etiology
Hedström, A. K. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458518801727 · Cited by 34
Quinn, J., & Axtell, R. C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103233 · Cited by 36
Familial multiple sclerosis patients have a shorter delay in diagnosis than sporadic cases
Steenhof, M., Stenager, E., Nielsen, N. M., Kyvik, K. O., Möller, S., & Hertz, J. M. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.04.012 · Cited by 34
The role of HLA variation in lymphoma aetiology and survival
Zhong, C., Cozen, W., Bolanos, R., Song, J. Y., & Wang, S. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12911 · Cited by 36
Contentti, E. C., Farez, M., & Correale, J. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02690 · Cited by 35
Maciak, K., Pietrasik, S., Dziedzic, A., Redlicka, J., Saluk, J., Bijak, M., Wlodarczyk, T. W., & Miller, E. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168946 · Cited by 35
Genetics and functional genomics of multiple sclerosis
Kim, W., & Patsopoulos, N. A. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-021-00907-3 · Cited by 39
Jalilian, B., Einarsson, H. B., & Vorup‐Jensen, T. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131114579 · Cited by 34
Fiebiger, S. M., Bros, H., Grobosch, T., Janssen, A., Chanvillard, C., Paul, F., Dörr, J., Millward, J. M., & Infante‐Duarte, C. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.07.002 · Cited by 34
Autoimmune Thyroid Disease in the Use of Alemtuzumab for Multiple Sclerosis: A Review
Aranha, A. A., Amer, S., Reda, E. S., Broadley, S., & Davoren, P. M. (2013) · Endocrine Practice · doi:10.4158/ep13020.ra · Cited by 35
Pharmacogenetic study of long-term response to interferon-β treatment in multiple sclerosis
Clarelli, F., Liberatore, G., Sorosina, M., Osiceanu, A. M., Esposito, F., Mascia, E., Santoro, S., Pavan, G., Colombo, B., Moiola, L., et al. (2015) · The Pharmacogenomics Journal · doi:10.1038/tpj.2015.85 · Cited by 34
Multiple sclerosis associated genetic variants ofCD226impair regulatory T cell function
Piédavent, M., Willing, A., Engler, J. B., Steinbach, K., Bauer, S., Eggert, B., Ufer, F., Kursawe, N., Wehrmann, S., Jäger, J., et al. (2015) · Brain · doi:10.1093/brain/awv256 · Cited by 36
High-throughput identification of noncoding functional SNPs via type IIS enzyme restriction
Li, G., Martínez‐Bonet, M., Wu, D., Yu, Y., Cui, J., Nguyen, H. N., Cunin, P., Levescot, A., Bai, M., Westra, H.-J., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0159-z · Cited by 35
Funk, C. C., Casella, A. M., Jung, S. C., Richards, M. A., Rodriguez, A., Shannon, P. T., Donovan-Maiye, R., Heavner, B., Chard, K., Xiao, Y., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108029 · Cited by 34
Genetic associations with brain cortical thickness in multiple sclerosis
Matsushita, T., Madireddy, L., Sprenger, T., Khankhanian, P., Magon, S., Naegelin, Y., Caverzasi, E., Lindberg, R. L. P., Kappos, L., Hauser, S. L., et al. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12190 · Cited by 34
A Multiple Sclerosis–Associated Variant of CBLB Links Genetic Risk with Type I IFN Function
Stürner, K. H., Borgmeyer, U., Schulze, C., Pleß, O., & Martinꝉ, R. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303077 · Cited by 33
GWAS-identified multiple sclerosis risk loci involved in immune response: Validation in Russians
Bashinskaya, V. V., Кулакова, О. Г., Сергеевич, К. И., Baulina, N., Favorov, A. V., Boyko, A. N., Tsareva, E., & Favorova, O. O. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.03.015 · Cited by 33
Vitamin A and systemic inflammation as protective factors in multiple sclerosis
Salzer, J., Hallmans, G., Nystrom, M. L., Stenlund, H. C., Wadell, G., & Sundström, P. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458512472752 · Cited by 33
Altin, J. A., Daley, S. R., Howitt, J. A., Rickards, H. J., Batkin, A. K., Horikawa, K., Prasad, S. J., Nelms, K. A., Kumar, S., Wu, L. C., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322739111 · Cited by 33
Grossman, I., Knappertz, V. A., Laifenfeld, D., Ross, C. J., Zeskind, B., Kolitz, S. E., Ladkani, D., Hayardeny, L., Loupe, P. S., Laufer, R., et al. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.02.001 · Cited by 34
Guan, M., Ma, J., Keaton, J. M., Dimitrov, L. M., Mudgal, P., Stromberg, M., Bonomo, J. A., Hicks, P. J., Freedman, B. I., Bowden, D. W., et al. (2016) · Human Genetics · doi:10.1007/s00439-016-1714-2 · Cited by 35
Invariant natural killer T cells and mucosal-associated invariant T cells in multiple sclerosis
Bianchini, E., Biasi, S. D., Simone, A. M., Ferraro, D., Sola, P., Cossarizza, A., & Pinti, M. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.01.009 · Cited by 33
Recent advances of induced pluripotent stem cells application in neurodegenerative diseases
Amin, N., Tan, X., Ren, Q., Zhu, N., Botchway, B. O. A., Hu, Z., & Fang, M. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109674 · Cited by 36
The emerging role of lncRNAs in multiple sclerosis
Ghaderian, S., Shomali, N., Behravesh, S., Danbaran, G. R., Hemmatzadeh, M., Aslani, S., Jadidi‐Niaragh, F., Hosseinzadeh, R., Torkamandi, S., & Mohammadi, H. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577347 · Cited by 33
Host Genetics and Gut Microbiome: Perspectives for Multiple Sclerosis
Maglione, A., Zuccalà, M., Tosi, M., Clerico, M., & Rolla, S. (2021) · Genes · doi:10.3390/genes12081181 · Cited by 34
Manu, M. S., Hohjoh, H., & Yamamura, T. (2021) · Aging and Disease · doi:10.14336/ad.2021.0513 · Cited by 34
ZMIZ proteins: partners in transcriptional regulation and risk factors for human disease
Lomelı́, H. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02216-0 · Cited by 33
Genome-wide association studies in neurology.
Tan, M., Jiang, T., Tan, L., & Yu, J. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2014.11.12 · Cited by 35
Cénit, M. C., Ortego‐Centeno, N., Raya, E., Callejas-Rubio, J. L., Hernández, F. J. G., Castillo‐Palma, M. J., FERNÁNDEZ-SUEIRO, J. L., Magro, C., Solans, R., Castañeda, S., et al. (2012) · Human Immunology · doi:10.1016/j.humimm.2012.10.019 · Cited by 33
Viruses and vitamin D in the etiology of type 1 diabetes mellitus and multiple sclerosis
Jankosky, C., Deussing, E. C., Gibson, R. L., & Haverkos, H. W. (2011) · Virus Research · doi:10.1016/j.virusres.2011.11.010 · Cited by 33
Liguori, M., Qualtieri, A., Tortorella, C., Direnzo, V., Bagalà, A., Mastrapasqua, M., Spadafora, P., & Trojano, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103984 · Cited by 33
Update on immunopathogenesis and immunotherapy in multiple sclerosis
Hemmer, B., & Selter (2013) · ImmunoTargets and Therapy · doi:10.2147/itt.s31813 · Cited by 33
Drug targets in the cytokine universe for autoimmune disease
Liu, X., Fang, L., Guo, T. B., Mei, H., & Zhang, J. Z. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.10.003 · Cited by 34
Li, C. F., Zhou, R. W., Mkhikian, H., Newton, B. L., Yu, Z., & Demetriou, M. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.12.008 · Cited by 37
Environmental factors in multiple sclerosis
Pantazou, V., Schluep, M., & Pasquier, R. D. (2015) · La Presse Médicale · doi:10.1016/j.lpm.2015.01.001 · Cited by 33
Gustafsson, M., Edström, M., Gawel, D. R., Nestor, C. E., Wang, H., Zhang, H., Barrenäs, F., Tojo, J., Kockum, I. S., Olsson, T. P., et al. (2014) · Genome Medicine · doi:10.1186/gm534 · Cited by 33
Lin, R., Taylor, B. V., Simpson, S., Charlesworth, J., Ponsonby, A., Pittas, F., Dwyer, T., & van der Mei, I. A. F. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305245 · Cited by 33
Ratzer, R. L., Søndergaard, H. B., Christensen, J. R., Börnsen, L. S., Borup, R., Sørensen, P. S., & Sellebjerg, F. T. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513500553 · Cited by 33
MYC: there is more to it than cancer
Fluck, M. F. Z., Soucek, L., & Whitfield, J. R. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1342872 · Cited by 35
Paciolla, C., Manganelli, M., Chiano, M. D., Montenegro, F., Gallone, A., Sallustio, F., & Guida, G. (2025) · Cells · doi:10.3390/cells14221823 · Cited by 35
Increased HLA ‐E expression in white matter lesions in multiple sclerosis
Durrenberger, P. F., Webb, L. V., Sim, M. J. W., Nicholas, R. S., Altmann, D. M., & Boyton, R. J. (2012) · Immunology · doi:10.1111/imm.12012 · Cited by 32
Vitamin D and multiple sclerosis: a critical review and recommendations on treatment
Faridar, A., Eskandari, G., Sahraian, M. A., Minagar, A., & Azimi, A. (2012) · Acta Neurologica Belgica · doi:10.1007/s13760-012-0108-z · Cited by 32
Revisiting the role of mast cells in autoimmunity
Yu, X., Kasprick, A., & Petersen, F. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.04.008 · Cited by 32
Is the IL-10 Promoter Polymorphism at Position -592 Associated with Immune System-Related Diseases?
Karimabad, M. N., Arababadi, M. K., Hakimizadeh, E., Yousefi-Daredor, H., Nazari, M., Hassanshahi, G., & Kennedy, D. D. (2012) · Inflammation · doi:10.1007/s10753-012-9517-7 · Cited by 32
Damotte, V., Guillot‐Noël, L., Patsopoulos, N. A., Madireddy, L., Behi, M. E., Ban, M., Baranzini, S. E., Barcellos, L. F., Beecham, G. W., Beecham, A. H., et al. (2014) · Genes and Immunity · doi:10.1038/gene.2013.70 · Cited by 33
Metadata
- Authors
- The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2
- Venue
- Nature
- Published
- 2011-08
- Volume
- 476
- Issue
- 7359
- Pages
- 214-219
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3182531
- OpenAlex
- W2040547343
- Cited by
- 2,697
- References
- 26
- Citations by year
- 2026: 72 · 2025: 101 · 2024: 112 · 2023: 111 · 2022: 136 · 2021: 155 · 2020: 167 · 2019: 173 · 2018: 178 · 2017: 215 · 2016: 220 · 2015: 273 · 2014: 244 · 2013: 279 · 2012: 223
- FWCI
- 175.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Keele Research Repository (Keele University) (submittedVersion, cc-by)
- PEARL (University of Plymouth) (submittedVersion)
- eCite Digital Repository (University of Tasmania) (submittedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Murdoch University Research Portal (submittedVersion)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion, cc-by-nc-sa)
- HAL (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Figshare (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Griffith Research Online (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Faculty of Health; Institute of Health and Biomedical Innovation
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Susan G. Komen for the Cure
- Biogen
- Kaiser Permanente
- Children's Hospital of Philadelphia
- Fondazione CRT
- Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques
- Institute of Clinical and Translational Sciences
- Scleroseforeningen
- Helsingin ja Uudenmaan Sairaanhoitopiiri
- Wellcome Trust (085475/Z/08/Z, 068545/Z/02), 085475, G0000934, 075491, 068545, 075491/Z/04,, 090532, 085475/B/08/Z, 084702)
- National Institute for Health and Care Research (G0000934, NF-SI-0507-10379, PDA/02/06/016)
- Parkinson's UK (G0909, J‐0804)
- Multiple Sclerosis Society (898/08)
- Multiple Sclerosis Australia
- Deutsche Forschungsgemeinschaft
- Agence Nationale de la Recherche (ANR-10-INBS-0001)
- Institut National de la Santé et de la Recherche Médicale
- Forskningsrådet för Arbetsliv och Socialvetenskap
- Academy of Finland
- Fonds Wetenschappelijk Onderzoek
- Ministero della Salute (502/92, D.lgs 502/92)
- Hjärnfonden
- Knut och Alice Wallenbergs Stiftelse
- Stockholms Läns Landsting (562183)
- Norges Forskningsråd
- Regione Piemonte (502/92)
- Haukeland Universitetssjukehus
- Vlaamse regering
- National Institutes of Health (5r01ns019142-03, G0000934, 075491/Z/04, 068545/Z/02, UL1TR000448, NS43559, NS19142, RR024992, CA104021, NS049477)
- U.S. Public Health Service (K23N/S048869)
- Medical Research Council (MC_EX_G0800860, 068545/Z/02, G0000934)
- National Health and Medical Research Council (G0000934)
- Helmholtz Zentrum München
- National Cancer Institute (R01CA104021, CA104021)
- National Institute of Allergy and Infectious Diseases (AI076544, R01AI076544)
- Fogarty International Center (K01TW009996)
- National Institute of Neurological Disorders and Stroke (NS067305, NS26799, NS 43559, NS032830, NS049477, NS19142, R01NS032830, R01NS043559, R01NS026799, R01NS049510, R01NS067305, NS049510, R01NS049477)
- National Center for Research Resources (RR020092, C06RR020092, RR-024992, UL1RR024992)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- multiple sclerosis, genetic susceptibility, genome-wide association study, major histocompatibility complex, T helper cell differentiation, cell-mediated immunity, neuroinflammation, neurodegeneration, pathogenesis, genetic susceptibility loci
- MeSH terms
- Alleles, Cell Differentiation, Europe, T-Lymphocytes, Helper-Inducer, HLA-DR Antigens, Humans, Immunity, Cellular, Major Histocompatibility Complex, Multiple Sclerosis, HLA-A Antigens, Genome, Human, Sample Size, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Genome-Wide Association Study, HLA-DRB1 Chains
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
